SCHEMBL7703309

SCHEMBL7703309

Oc1ccc2c(c1)CC[C@@H](CNCCc1ccccc1)[C@H]2c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
GRIN2B Q13224 2/20 0.46
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
ESR1 P03372 5/20 0.44
ESR2 Q92731 1/20 0.43
SLC2A1 P11166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703316 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL7702709 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL7700454 0.86 MTNR1A (0.42) ALDH1A1SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL7702593 0.86 MTNR1A (0.42) ALDH1A1SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL7706107 0.86 MTNR1A (0.42) ALDH1A1SMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL7703433 0.85 BCHE (0.51) GRIN2BSLC2A1
SCHEMBL7703443 0.85 BCHE (0.51) GRIN2BSLC2A1
SCHEMBL7701272 0.85 BCHE (0.51) GRIN2BSLC2A1
SCHEMBL7698356 0.84 MTNR1A (0.40) ALDH1A1SMN1; SMN2GRIN2BMTNR1AMTNR1B
SCHEMBL7700173 0.84 SLC6A9 (0.58) GRIN2BMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed